Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 7:42 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 80 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: PEG3350 Clear all

Conditions: Colonoscopy Preparation
Interventions: polyethylene glycol, senna; Drug
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 6 Years to 21 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Bowel Preparation
Interventions: CLENPIQ, MIRALAX, SENNA; Drug
Lead sponsor: Ferring Pharmaceuticals; Industry
Eligibility: 12 Months to 8 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 4
States / cities: Mobile, Alabama • San Diego, California • Baltimore, Maryland

Conditions: Bowel Preparation for Colonoscopy
Interventions: PEG-ELS (Golytely), Miralax mixed with Gatorade, Miralax; Drug
Lead sponsor: Southern California Institute for Research and Education; Other
Eligibility: 18 Years to 80 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Long Beach, California

Conditions: Colonoscopy
Interventions: polyethylene glycol 3350; Drug
Lead sponsor: Walter Reed National Military Medical Center; Federal
Eligibility: 8 Years to 18 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Constipation
Interventions: PEG 3350, milk and molasses enema; Drug
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 1 Year to 17 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Crohn Disease
Interventions: Vancomycin, Neomycin, Ciprofloxacin, Polyethylene Glycol 3350, Fluconazole; Drug
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 6 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Autism Spectrum Disorder, Gastro-Intestinal Disorder, Constipation, Diarrhea
Interventions: vancomycin, Miralax, intestinal microbiota, placebo vancomycin, Miralax, placebo intestinal microbiota; Combination Product
Lead sponsor: Arizona State University; Other
Eligibility: 5 Years to 17 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Crohn's Disease
Interventions: Fluconazole, Vancomycin, Neomycin, Ciprofloxacin, Polyethylene Glycol 3350, Promethazine, Fluconazole placebo; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 75 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Clostridium Difficile Colitis
Interventions: Ileal diversion and lavage, total abdominal colectomy; Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cystic Fibrosis Gastrointestinal Disease
Interventions: Polyethylene Glycol 3350, SmartPill Motility System & PillCam Patency Capsule; Drug · Device
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 2
States / cities: St Louis, Missouri

Conditions: Preparation for Colonoscopy
Interventions: Bowel Preparation; Drug
Lead sponsor: Gastroenterology Services, Ltd.; Other
Eligibility: 18 Years and older
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Downers Grove, Illinois

Conditions: Constipation, Post-Op Complication
Interventions: Polyethylene Glycol Powder; Drug
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 89 Years · Female only
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Bay Shore, New York

Conditions: Constipation
Interventions: Polyethylene Glycol 3350; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older · Female only
Enrollment: 97 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Constipation
Interventions: Naloxegol Oral Tablet, Placebo Oral Tablet, Docusate Sodium 100 Mg oral capsule [Colace], Senna 217 Mg Oral Tablet, Polyethylene Glycols, Bisacodyl 10 mg Suppository, Magnesium Citrate Oral Liquid Product, Methylnaltrexone; Drug
Lead sponsor: Tufts Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Colonoscopy
Interventions: BLI-800, Polyethylene glycol 3350 based bowel preparation; Drug
Lead sponsor: Braintree Laboratories; Industry
Eligibility: 18 Years and older
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 10
States / cities: Anaheim, California • Orange, California • Jackson, Mississippi + 7 more

Conditions: Colonoscopy
Interventions: HalfLytely and Bisacodyl Tablets - Formulation 1, HalfLytely and Bisacodyl Tablets - Formulation 2, NuLYTELY; Drug
Lead sponsor: Braintree Laboratories; Industry
Eligibility: 6 Years to 16 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 26
States / cities: Birmingham, Alabama • Mobile, Alabama • Tuscaloosa, Alabama + 23 more

Conditions: Colonoscopy
Interventions: Golytely (polyethylene glycol), MiraLax (polyethylene glycol 3350); Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 50 Years to 90 Years
Enrollment: 432 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Constipation
Interventions: PEG3350; Drug
Lead sponsor: Braintree Laboratories; Industry
Eligibility: 4 Years to 16 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 2
States / cities: Little Rock, Arkansas • Morristown, New Jersey

Conditions: Infection, Human Immunodeficiency Virus, HIV Infections
Interventions: CAB Oral Tablets, CAB LA, ABC/3TC Oral tablets, RPV Oral Tablets, HAART, RPV; Drug · Other
Lead sponsor: ViiV Healthcare; Industry
Eligibility: 18 Years and older
Enrollment: 309 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2023
U.S. locations: 15
States / cities: Birmingham, Alabama • Bakersfield, California • Beverly Hills, California + 12 more

Conditions: Colonoscopy
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 5 Years to 21 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Colonoscopy
Interventions: BLI800, Polyethylene glycol 3350 based bowel preparation; Drug
Lead sponsor: Braintree Laboratories; Industry
Eligibility: 18 Years and older
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2009
U.S. locations: 5
States / cities: Mobile, Alabama • Jupiter, Florida • Miami, Florida + 2 more

Conditions: Hepatic Encephalopathy, Cirrhosis, Portosystemic Encephalopathy, PSE
Interventions: Polyethylene glycol 3350-electrolyte solution (GoLYTELY®), Lactulose; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Adenomatous Polyp, Colorectal Carcinoma
Interventions: macrogol 3350-based oral osmotic laxative, Placebo, Laboratory Biomarker Analysis; Drug · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 87 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 3
States / cities: Chicago, Illinois • Evanston, Illinois • Boston, Massachusetts

Conditions: Colorectal Cancer
Interventions: Miralax-Gatorade Prep, Golytely; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 2,239 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Search by objective public record fields.

Bowel Preparation for Colonoscopy in Children

Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy

A Study Comparing PEG-3350 (Miralax) and Gatorade With PEG-ELS (Golytely) for Bowel Preparation Prior to Colonoscopy

Short Course, Single-dose PEG 3350 for Colonoscopy Prep in Children

Comparison Trial of Enema vs. PEG 3350 for Constipation

Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease

MTT for Children With ASD Who Have Gastrointestinal Disorders

Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease

Optimal Surgical Treatment Of Fulminant Clostridium Difficile Colitis

Cystic Fibrosis and Gut Dysmotility: The Effect of Polyethylene Glycol (PEG) on Intestinal Transit

Safety and Efficacy of High Dose Bowel Preparation Solutions for Patients With Difficult To Clean Colons For Colonoscopy

Does a Preoperative Bowel Regimen Change Time to First Bowel Movement After Robotic Sacral Colpopexy

Bowel Function After Minimally Invasive Hysterectomy

Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered Opioids

BLI-800-302: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

A Safety and Efficacy Evaluation of 3 Bowel Preparations in the Pediatric Population

A Trial Comparing Bowel Preparation and Patient Tolerability of Miralax Versus Golytely

A Pilot Study of a New PEG3350 Dose Formulation For Use in Constipated Children

A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects

The Efficacy Side Effects and the Tolerance of Polyethylene Glycol 3350 as a Bowel Prep in Children

BLI800-303: An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects

Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy.

Macrogol 3350-based Oral Osmotic Laxative in Preventing Cancer in Patients at Risk of Colorectal Cancer

Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens